Doctors and patients are not recognising early signs of diabetic ketoacidosis triggered by SGLT2 inhibitors, a review of 13 cases in South Australia has shown. The life-threatening condition was often being missed due to relative euglycaemia, resulting in delayed treatment, according to a report by endocrinologist Dr Emily Mayer and colleagues at the Royal Adelaide ...
DKA missed in patients taking SGLT2 inhibitors, SA review finds
By Michael Woodhead
14 Feb 2018